LDHA and ductal breast carcinoma in situ: AZD6244 treatment significantly reduced phospho-ERK, phospho-CREB and LDHA levels in DCIS.COM.ζ and DCIS.COM.Vec tumors compared to vehicle treatment (Figure 5C and Supplementary Table S4).